Tailored Approaches to Improve Medication Adherence

Completed · Not applicable

Conditions studied: Hypertension

In brief

The purpose of this study is to to culturally tailor a technology-based individualized adherence intervention for Black and Latino patients with uncontrolled HTN or T2DM, who are non-adherent to their medications, and determine its acceptability.

Key facts

Study ID

NCT01643473

Run by

NYU Langone Health

People needed

42

Starts

2013-04-01

Expected to finish

2018-05-01

Last updated by the study team

2019-09-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have uncontrolled hypertension defined as BP>140/90 mmHg on at least two consecutive visits in the past year (or BP>130/80 mmHg for those with diabetes or kidney disease) and Framingham Risk Scores (FRS) >20% (or at least one CVD risk factor including hyperlipidemia or diabetes);
• Have been prescribed at least one antihypertensive or oral anti-diabetic medication;
• Self-identify as Latino or African American/Black
• Be > 18 years of age

You may not qualify if…

• Refuse or are unable to provide informed consent;
• Currently participate in another hypertension study; or 2 diabetes study
• Have significant psychiatric comorbidity
• Plan to discontinue care at the clinic within the next 3 months
• Vulnerable populations including adults unable to provide informed consent, pregnant women, and prisoners will be excluded from this study.

Where it is running

• Union Health Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.